Mechanistic Basis for the Recognition of a Misfolded Protein by the Molecular Chaperone Hsp90

Overview

Journal Nat Struct Mol Biol

Specialties Cell Biology
Molecular Biology

Date 2017 Feb 21

PMID 28218749

Citations 25

Authors

Javier Oroz

Jin Hae Kim

Bliss J Chang

Markus Zweckstetter

Affiliations

Soon will be listed here.

Abstract

The critical toxic species in over 40 human diseases are misfolded proteins. Their interaction with molecular chaperones such as Hsp90, which preferentially interacts with metastable proteins, is essential for the blocking of disease progression. Here we used nuclear magnetic resonance (NMR) spectroscopy to determine the three-dimensional structure of the misfolded cytotoxic monomer of the amyloidogenic human protein transthyretin, which is characterized by the release of the C-terminal β-strand and perturbations of the A-B loop. The misfolded transthyretin monomer, but not the wild-type protein, binds to human Hsp90. In the bound state, the Hsp90 dimer predominantly populates an open conformation, and transthyretin retains its globular structure. The interaction surface for the transthyretin monomer comprises the N-terminal and middle domains of Hsp90 and overlaps with that of the Alzheimer's-disease-related protein tau. Taken together, the data suggest that Hsp90 uses a mechanism for the recognition of aggregation-prone proteins that is largely distinct from those of other Hsp90 clients.

Citing Articles

Zn(ii)-driven impact of monomeric transthyretin on amyloid-β amyloidogenesis.

Yi Y, Kim B, Kim M, Ko Y, Kim J, Lim M Chem Sci. 2025; 16(10):4366-4373.

PMID: 39911331 PMC: 11793109. DOI: 10.1039/d4sc08771b.

Insights into the Allosteric Regulation of Human Hsp90 Revealed by NMR Spectroscopy.

Gorican T, Golic Grdadolnik S Biomolecules. 2025; 15(1).

PMID: 39858432 PMC: 11761240. DOI: 10.3390/biom15010037.

The known unknowns of the Hsp90 chaperone.

Silbermann L, Vermeer B, Schmid S, Tych K Elife. 2024; 13.

PMID: 39737863 PMC: 11687934. DOI: 10.7554/eLife.102666.

Structural Basis for Monoclonal Antibody Therapy for Transthyretin Amyloidosis.

Chakrabartty A Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338387 PMC: 11435174. DOI: 10.3390/ph17091225.

Insights into Plant Sensory Mechanisms under Abiotic Stresses.

Jin S, Wei M, Wei Y, Jiang Z Plants (Basel). 2024; 13(14).

PMID: 39065434 PMC: 11280238. DOI: 10.3390/plants13141907.

References

Echeverria P, Picard D . Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility. Biochim Biophys Acta. 2009; 1803(6):641-9. DOI: 10.1016/j.bbamcr.2009.11.012. View

Falsone S, Kungl A, Rek A, Cappai R, Zangger K . The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein. J Biol Chem. 2009; 284(45):31190-9. PMC: 2781518. DOI: 10.1074/jbc.M109.057240. View

Street T, Lavery L, Agard D . Substrate binding drives large-scale conformational changes in the Hsp90 molecular chaperone. Mol Cell. 2011; 42(1):96-105. PMC: 3105473. DOI: 10.1016/j.molcel.2011.01.029. View

Delaglio F, Grzesiek S, Vuister G, Zhu G, Pfeifer J, Bax A . NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995; 6(3):277-93. DOI: 10.1007/BF00197809. View

Tugarinov V, Kanelis V, Kay L . Isotope labeling strategies for the study of high-molecular-weight proteins by solution NMR spectroscopy. Nat Protoc. 2007; 1(2):749-54. DOI: 10.1038/nprot.2006.101. View

Guntert P . Automated NMR structure calculation with CYANA. Methods Mol Biol. 2004; 278:353-78. DOI: 10.1385/1-59259-809-9:353. View

Dekki N, Refai E, Holmberg R, Kohler M, Jornvall H, Berggren P . Transthyretin binds to glucose-regulated proteins and is subjected to endocytosis by the pancreatic β-cell. Cell Mol Life Sci. 2011; 69(10):1733-43. PMC: 11114638. DOI: 10.1007/s00018-011-0899-8. View

Chakraborty R, Muchtar E, Gertz M . Newer Therapies for Amyloid Cardiomyopathy. Curr Heart Fail Rep. 2016; 13(5):237-246. DOI: 10.1007/s11897-016-0300-1. View

Zhang M, Kadota Y, Prodromou C, Shirasu K, Pearl L . Structural basis for assembly of Hsp90-Sgt1-CHORD protein complexes: implications for chaperoning of NLR innate immunity receptors. Mol Cell. 2010; 39(2):269-81. PMC: 2935968. DOI: 10.1016/j.molcel.2010.05.010. View

10.

Lindberg I, Shorter J, Wiseman R, Chiti F, Dickey C, McLean P . Chaperones in Neurodegeneration. J Neurosci. 2015; 35(41):13853-9. PMC: 4604223. DOI: 10.1523/JNEUROSCI.2600-15.2015. View

11.

Sreedhar A, Kalmar E, Csermely P, Shen Y . Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett. 2004; 562(1-3):11-5. DOI: 10.1016/s0014-5793(04)00229-7. View

12.

Reixach N, Deechongkit S, Jiang X, Kelly J, Buxbaum J . Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci U S A. 2004; 101(9):2817-22. PMC: 365703. DOI: 10.1073/pnas.0400062101. View

13.

Chen J, Genereux J, Suh E, Vartabedian V, Rius B, Qu S . Endoplasmic Reticulum Proteostasis Influences the Oligomeric State of an Amyloidogenic Protein Secreted from Mammalian Cells. Cell Chem Biol. 2016; 23(10):1282-1293. PMC: 5108364. DOI: 10.1016/j.chembiol.2016.09.001. View

14.

Keizers P, Saragliadis A, Hiruma Y, Overhand M, Ubbink M . Design, synthesis, and evaluation of a lanthanide chelating protein probe: CLaNP-5 yields predictable paramagnetic effects independent of environment. J Am Chem Soc. 2008; 130(44):14802-12. DOI: 10.1021/ja8054832. View

15.

Pintacuda G, John M, Su X, Otting G . NMR structure determination of protein-ligand complexes by lanthanide labeling. Acc Chem Res. 2007; 40(3):206-12. DOI: 10.1021/ar050087z. View

16.

Lim K, Dasari A, Hung I, Gan Z, Kelly J, Wemmer D . Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR. Biochemistry. 2016; 55(13):1941-4. PMC: 4904294. DOI: 10.1021/acs.biochem.6b00164. View

17.

Bukau B, Weissman J, Horwich A . Molecular chaperones and protein quality control. Cell. 2006; 125(3):443-51. DOI: 10.1016/j.cell.2006.04.014. View

18.

Tugarinov V, Hwang P, Kay L . Nuclear magnetic resonance spectroscopy of high-molecular-weight proteins. Annu Rev Biochem. 2004; 73:107-46. DOI: 10.1146/annurev.biochem.73.011303.074004. View

19.

Marion D, Driscoll P, Kay L, Wingfield P, Bax A, Gronenborn A . Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three-dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy:.... Biochemistry. 1989; 28(15):6150-6. DOI: 10.1021/bi00441a004. View

20.

Bhattacharya A, Tejero R, Montelione G . Evaluating protein structures determined by structural genomics consortia. Proteins. 2006; 66(4):778-95. DOI: 10.1002/prot.21165. View